Pharmaceuticals, Biotechnology and Life Sciences
CPhI Middle East & Africa has been cancelled due to the COVID-19 pandemic, the 2020 edition of the show, scheduled to take place in September in Abu Dhabi. A new earlier date and location for the event has been disclosed, with the show debuting in Riyadh, Saudi Arabia on March 2021.
UBM’s pharma portfolio will launch a new biopharma event, BioLive, next year in Madrid – specifically for bioprocessing and manufacturing. The new event has been…
CPhI Worldwide – held in Frankfurt, October 24-26 and organised by UBM – announces the findings of part i of the 5th edition of the CPhI Annual…
CPhI Korea, organized by UBM, closed its doors in Seoul after another record-breaking event that attracted 4,300 attendees and 147…
CPhI Korea returns to Seoul COEX Convention and Exhibition Centre for its fourth edition from 22nd-24th August 2017. The show will co-locate with ICSE, P-MEC, BioPh and Health Ingredients Korea. Reflecting the global interest in the South Korean pharma market, CPhI Korea 2017 will see a 13% rise in the number of exhibitors, in addition to a more than doubling of overseas buyers since 2015.
Omya said Wednesday it will showcase its Omyapharm multifunctional excipient platform based on functionalized calcium carbonate, a highly structured mineral At CPhI in Frankfurt.
Girish Malhotra, President of EPCOT International, and CPhI Worldwide Annual Industry Report member, discusses the necessity of time reduction for ANDA approvals, arguing that if the current approval time can be reduced from ten months to three months, drug costs will decrease.
An ageing population, a growing generics market and liberalization of Over-The-Counter medicines make Japan an attractive destination for investments, particularly as the pharma industry undergoes legislative change, with the Government’s bid to cut healthcare expenditure.
UBM EMEA announces the rebranding and relocation of CPhI Istanbul into CPhI Middle East & Africa, which will open next year (3-5 September 2018) at ADNEC Centre, Abu Dhabi, United Arab Emirates (UAE).
With the goal of developing Turkey as an R&D and technology hub, the Government has put place a number of measures to stimulate expansion of biotechnology and biopharmaceutical activities.